Literature DB >> 1261583

Hemodynamic effects of verapamil and practolol in man.

R Seabra-Gomes, A Rickards, R Sutton.   

Abstract

The hemodynamic effects of verapamil and practolol were investigated in a group of 10 selected patients (7 with coronary artery disease) undergoing cardiac catherization. The drugs were given i.v. in a dose of 0.1 mg/kg, alone or in combination, before and after controling the heart rate by atrial pacing. Measured hemodynamic parameters included aortic and left ventricular pressure and its first derivative, cardiac output, and echocardiographically derived left ventricular dimensions. Each drug given individually caused minor hemodynamic changes, but the combination of practolol and verapamil when the heart rate was fixed by atrial pacing invaribly caused a reduction in LV dp/dt max which was independent of preload and afterload. It is concluded that both drugs have a mildly negative inotropic effect when administered at this dose intravenously to patients with normal or mildly impaired left ventricular function. The myocardial depression was more apparent when practolol preceded verpamil. Caution must be exercised when using these drugs in combination in patients with impaired myocardial function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261583

Source DB:  PubMed          Journal:  Eur J Cardiol        ISSN: 0301-4711


  14 in total

1.  Echocardiography in cardiovascular drug assessment.

Authors:  M A Martin; N R Fieller
Journal:  Br Heart J       Date:  1979-05

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Drug interactions and beta blockers.

Authors:  L Beeley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

Review 4.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

5.  Additive antianginal effect of verapamil in patients receiving propranolol.

Authors:  G P Spickett
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

Review 6.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

7.  Effects of intravenous verapamil on left ventricular systolic function and diastolic filling dynamics in patients with coronary artery disease: analysis of intramyocardial markers.

Authors:  I Amende; R Simon; A Seegers; W P Hood; H D Schmittenkoetter
Journal:  Int J Card Imaging       Date:  1988

Review 8.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 9.  Clinical pharmacokinetics of verapamil.

Authors:  S R Hamann; R A Blouin; R G McAllister
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 10.  Calcium antagonists. Clinical use in the treatment of arrhythmias.

Authors:  B N Singh; K Nademanee; S H Baky
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.